Evidence map›Paper›PMID 24207100›Full record

ReviewEmerging infectious diseases2013

Tropheryma whipplei endocarditis.

Florence Fenollar, Marie Célard, Jean-Christophe Lagier, Hubert Lepidi, Pierre-Edouard Fournier, Didier Raoult

Abstract readCase ReportsReview
In one paragraph

Review in Emerging infectious diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Molecular frequency ofNew microbes and new infections · 2026
    Article
  2. Rare but Critical: SevereClinical case reports · 2026
    Article
  3. Pulmonary infection caused byTranslational pediatrics · 2026
    Article
  4. Article
  5. Case reports in cardiology · 2026
    Article
  6. A new case ofOxford medical case reports · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. [Endocarditis and ischemic stroke of rare cause].Innere Medizin (Heidelberg, Germany) · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Updates in Culture-Negative Endocarditis.Pathogens (Basel, Switzerland) · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. A Massive Number of ExtracellularFrontiers in immunology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Florence Fenollar
Marie Célard
Jean-Christophe Lagier
Hubert Lepidi
Pierre-Edouard Fournier
Didier Raoult

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tropheryma whipplei endocarditis differs from classic Whipple disease, which primarily affects the gastrointestinal system. We diagnosed 28 cases of T. whipplei endocarditis in Marseille, France, and compared them with cases reported in the literature. Specimens were analyzed mostly by molecular and histologic techniques. Duke criteria were ineffective for diagnosis before heart valve analysis. The disease occurred in men 40-80 years of age, of whom 21 (75%) had arthralgia (75%); 9 (32%) had valvular disease and 11 (39%) had fever. Clinical manifestations were predominantly cardiologic. Treatment with doxycycline and hydroxychloroquine for at least 12 months was successful. The cases we diagnosed differed from those reported from Germany, in which arthralgias were less common and previous valve lesions more common. A strong geographic specificity for this disease is found mainly in eastern-central France, Switzerland, and Germany. T. whipplei endocarditis is an emerging clinical entity observed in middle-aged and older men with arthralgia.

Indexed as

TropherymaAdultAgedAged, 80 and overEndocarditis, BacterialEuropeHeart ValvesHumansImmunosuppressive AgentsMaleMiddle AgedTreatment OutcomeWhipple DiseaseImmunosuppressive AgentsarthralgiabacteriaendocarditisTropheryma whippleiWhipple diseaseWhipple’s disease

Identifiers

PMID24207100
PMCPMC3837638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.